Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMTOTCMKTS:ADMTOTCMKTS:AKSYOTCMKTS:REMI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00-75.0%$0.00$0.00▼$0.00N/A1.56N/A22,000 shsADMTADM Tronics Unlimited$0.05-11.6%$0.06$0.03▼$0.11$3.79M-0.065,474 shs875 shsAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AREMIRemedent$0.01$0.02$0.01▼$0.07N/A-0.1980 shsN/A20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%+33.33%-33.33%ADMTADM Tronics Unlimited0.00%0.00%+1.82%-18.84%-15.85%AKSYAksys0.00%0.00%0.00%0.00%0.00%REMIRemedent0.00%0.00%0.00%-80.00%-83.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AN/AN/AREMIRemedentN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/AADMTADM Tronics Unlimited 0.00N/AN/AN/AAKSYAksys 0.00N/AN/AN/AREMIRemedent 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical Technologies$270KN/AN/AN/AN/AN/AADMTADM Tronics Unlimited$2.96M1.13N/AN/AN/A∞AKSYAksysN/AN/AN/AN/AN/AN/AREMIRemedent$990KN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical Technologies-$510KN/A0.00∞N/AN/AN/AN/AN/AADMTADM Tronics Unlimited-$880KN/A0.00∞N/A-13.47%-49.27%-18.74%7/14/2025 (Estimated)AKSYAksysN/AN/A0.00N/AN/AN/AN/AN/AN/AREMIRemedent-$270K-$0.01N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AREMIRemedentN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABMTAdvanced Biomedical TechnologiesN/AN/AN/AADMTADM Tronics UnlimitedN/A1.210.78AKSYAksysN/AN/AN/AREMIRemedentN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/AADMTADM Tronics UnlimitedN/AAKSYAksysN/AREMIRemedentN/AInsider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%ADMTADM Tronics Unlimited73.00%AKSYAksys3.80%REMIRemedentN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies20N/AN/ANot OptionableADMTADM Tronics Unlimited2367.59 million18.25 millionNot OptionableAKSYAksys87N/AN/ANot OptionableREMIRemedent4N/AN/ANot OptionableREMI, ADMT, ABMT, and AKSY HeadlinesRecent News About These CompaniesRemedent (REMI) and Its Peers Head to Head AnalysisJuly 6 at 2:09 AM | americanbankingnews.comHead to Head Analysis: Remedent (REMI) vs. The CompetitionJuly 3, 2025 | americanbankingnews.comEx-Chelsea striker looks like completely new person just one year after retirementAugust 28, 2024 | mirror.co.ukMTikTok star Remi Bader shares fitness transformation after slamming trolls over weight criticismMay 25, 2024 | pagesix.comPRemi Bader Shows Off Body Transformation After 'Putting Myself First': 'This Is Not About Weight or Looks'May 25, 2024 | people.comPRémi Laurent Biography & MoviesApril 29, 2024 | tribute.caTRémi Laurent Biography & MoviesApril 29, 2024 | tribute.caTREMYY Rémy Cointreau SAApril 24, 2024 | seekingalpha.comRemi LambertFebruary 29, 2024 | thesun.co.ukPeterson RemyFebruary 15, 2024 | health.usnews.comRemi MonaghanJanuary 10, 2024 | fox17online.comFremy ma and papooseDecember 6, 2023 | hiphopwired.comHRémi Bonnet Breaks Longtime Pikes Peak Ascent RecordSeptember 25, 2023 | runnersworld.comRHome and Away spoiler: Remi keeps quiet about the kissAugust 20, 2023 | digitalspy.comDRemi Wolf Returns with New Single “Prescription,” Inspired by Phone Call with Boots Riley: StreamJune 2, 2023 | yahoo.comHome and Away spoilers: Remi collapses in Salt as his injury worsensMarch 27, 2023 | metro.co.ukMLove Island star Remi Lambert claims he was assaulted by one of Jacques O'Neill's friendsMarch 22, 2023 | mirror.co.ukMRemi Matthews focuses on the present with St JohnstoneMarch 17, 2023 | irishnews.comILioness of Bourdillon: How Remi Tinubu Becomes the New Beautiful BrideMarch 7, 2023 | thisdaylive.comTRemi Bader shares what happened to her when she stopped taking OzempicFebruary 5, 2023 | today.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendSoFi Stock’s Next Test: Can It Justify Its Premium Valuation?By Chris Markoch | June 13, 2025View SoFi Stock’s Next Test: Can It Justify Its Premium Valuation?Super Micro’s Bold $2B Bond Plan Signals 35% Premium UpsideBy Gabriel Osorio-Mazilli | June 26, 2025View Super Micro’s Bold $2B Bond Plan Signals 35% Premium UpsideREMI, ADMT, ABMT, and AKSY Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMT$0.0001 0.00 (-75.00%) As of 12:32 PM EasternAdvanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.ADM Tronics Unlimited OTCMKTS:ADMT$0.05 -0.01 (-11.61%) As of 03:13 PM EasternADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.Aksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.Remedent OTCMKTS:REMI$0.01 0.00 (0.00%) As of 07/3/2025Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
